论文部分内容阅读
目的:探讨阿德福韦酯联合拉米夫定治疗乙型肝炎肝硬化失代偿期患者的临床效果。方法:选取昆明市第三人民医院在2014年8月至2015年8月时间段内收治的98例乙型肝炎肝硬化失代偿期患者,随机的将患者平均分成观察组和对照组,实施不同的用药方案,观察和对比两组效果。结果:治疗后两组患者的各相关指标都所有改善,且观察组患者改善的情况明显优于对照组,差异有统计学意义(P<0.05)。结论在对乙型肝炎肝硬化失代偿期患者进行治疗的过程中采用阿德福韦酯联合拉米夫定方案,效果显著。
Objective: To investigate the clinical effect of adefovir dipivoxil combined with lamivudine in the treatment of patients with decompensated hepatitis B cirrhosis. Methods: A total of 98 patients with decompensated hepatitis B cirrhosis who were admitted to Kunming Third People’s Hospital from August 2014 to August 2015 were randomly divided into observation group and control group Different medication programs, observation and comparison of two groups of results. Results: After treatment, all the relevant indicators of both groups improved, and the improvement of the observation group was better than that of the control group, the difference was statistically significant (P <0.05). Conclusions The adefovir dipivoxil combined with lamivudine regimen is effective in the treatment of patients with decompensated hepatitis B cirrhosis.